These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 2718887)

  • 21. Anti-idiotypic antibodies to the third variable domain of gp120 induce an anti-HIV-1 antibody response in mice.
    Boudet F; Theze J; Zouali M
    Virology; 1994 Apr; 200(1):176-88. PubMed ID: 7510435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Detection of antibodies to the surface (anti-p-41) and nuclear protein (anti-p-24) of the human immunologic deficiency virus (HIV)].
    Hess G; Kroegel C; Ramadori G; Rieder H; Meyer zum Büschenfelde KH
    Med Klin (Munich); 1987 Oct; 82(21):723-5, 761. PubMed ID: 3500393
    [No Abstract]   [Full Text] [Related]  

  • 23. Lysis of cells infected with HIV-1 by human lymphocytes targeted with monoclonal antibody heteroconjugates.
    Zarling JM; Moran PA; Grosmaire LS; McClure J; Shriver K; Ledbetter JA
    J Immunol; 1988 Apr; 140(8):2609-13. PubMed ID: 2965725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of three monoclonal antibodies (VAK3-5) that identify p24, core protein of human immunodeficiency virus, and its precursors.
    Hattori T; Sagawa K; Matsushita S; Koito A; Suto H; Matsuoka M; Yokoyama M; Takatsuki K
    Jpn J Cancer Res; 1987 Mar; 78(3):235-41. PubMed ID: 3106279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Production and characterization of mouse monoclonal antibodies against the transmembrane protein of a human immunodeficiency virus type 2.
    Komatsu H; Yamashita A; Tozawa H; Mizutani Y; Honda M; Kawamura M; Hayami M
    AIDS Res Hum Retroviruses; 1991 Dec; 7(12):999-1005. PubMed ID: 1725959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human monoclonal antibody against glycoproteins of human immunodeficiency virus.
    Sugano T; Masuho Y; Matsumoto Y; Lake D; Gschwind C; Petersen EA; Hersh EM
    Biochem Biophys Res Commun; 1988 Sep; 155(3):1105-12. PubMed ID: 2845963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neutralizing monoclonal antibodies to the AIDS virus.
    Thomas EK; Weber JN; McClure J; Clapham PR; Singhal MC; Shriver MK; Weiss RA
    AIDS; 1988 Feb; 2(1):25-9. PubMed ID: 2451922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoclonal antibodies to the human immunodeficiency virus p18 protein cross-react with normal human tissues.
    Parravicini CL; Klatzmann D; Jaffray P; Costanzi G; Gluckman JC
    AIDS; 1988 Jun; 2(3):171-7. PubMed ID: 2456086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody-dependent cellular cytotoxicity is directed against both the gp120 and gp41 envelope proteins of HIV.
    Evans LA; Thomson-Honnebier G; Steimer K; Paoletti E; Perkus ME; Hollander H; Levy JA
    AIDS; 1989 May; 3(5):273-6. PubMed ID: 2548535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monitoring of specific antibodies to human immunodeficiency virus structural proteins: clinical significance.
    Allain JP; Laurian Y; Einstein MH; Braun BP; Delaney SR; Stephens JE; Daluga CK; Dahlen SJ; Knigge KM
    Blood; 1991 Mar; 77(5):1118-23. PubMed ID: 1671648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of large glycosylated proteins recognized by monoclonal antibodies against HIV-1 gag proteins.
    Pinter A; Honnen WJ; Revesz K; Herz R
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1341-4. PubMed ID: 1466953
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical importance of HIV antigen and anti-HIV core markers in persons infected with HIV.
    Lelie PN; Reesink HW; Bakker E; Huisman JG; ten Veen JH
    N Engl J Med; 1988 May; 318(18):1204-5. PubMed ID: 3163101
    [No Abstract]   [Full Text] [Related]  

  • 33. The immunopathogenesis of HIV infection.
    Rosenberg ZF; Fauci AS
    Adv Immunol; 1989; 47():377-431. PubMed ID: 2573256
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical and biological features in the 12 months preceding onset of AIDS in HIV-infected subjects.
    Lefrere JJ; Courouce AM; Lambin P; Fine JM; Doinel C; Salmon C
    J Acquir Immune Defic Syndr (1988); 1989; 2(1):100-1. PubMed ID: 2493092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human monoclonal antibody against a gag-coded protein of human immunodeficiency virus produced by a stable EBV-transformed cell clone.
    Amadori A; Ciminale V; Calabro ML; Tessarollo L; Francavilla E; Chieco-Bianchi L
    AIDS Res Hum Retroviruses; 1989 Feb; 5(1):73-8. PubMed ID: 2541750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase I trial of potential AIDS vaccine commences.
    Oncology (Williston Park); 1991 May; 5(5):182. PubMed ID: 1832002
    [No Abstract]   [Full Text] [Related]  

  • 37. The human immunodeficiency viruses. Detection and pathogenesis.
    Levy JA
    Immunol Ser; 1989; 44():159-229. PubMed ID: 2489112
    [No Abstract]   [Full Text] [Related]  

  • 38. Neutralisation of HIV isolates by anti-idiotypic antibodies which mimic the T4 (CD4) epitope: a potential AIDS vaccine.
    Dalgleish AG; Thomson BJ; Chanh TC; Malkovsky M; Kennedy RC
    Lancet; 1987 Nov; 2(8567):1047-50. PubMed ID: 2444842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [AIDS infection status of mothers. The blood of newborn infants as an indicator].
    Fortschr Med; 1989 Mar; 107(10):12. PubMed ID: 2714722
    [No Abstract]   [Full Text] [Related]  

  • 40. Characterization of monoclonal antibodies against the human immunodeficiency virus (HIV) gag products and their use in monitoring HIV isolate variation.
    Ferns RB; Tedder RS; Weiss RA
    J Gen Virol; 1987 Jun; 68 ( Pt 6)():1543-51. PubMed ID: 2438375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.